Get the Stockscreener App
5.38
3.07%
0.16
After Hours:
5.23
-0.15
-2.79%
Personalis Inc stock is traded at $5.38, with a volume of 677.04K.
It is up +3.07% in the last 24 hours and down -1.10% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$5.22
Open:
$5.18
24h Volume:
677.04K
Relative Volume:
0.46
Market Cap:
$344.18M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-2.2797
EPS:
-2.36
Net Cash Flow:
$-67.17M
1W Performance:
+6.22%
1M Performance:
-1.10%
6M Performance:
+261.07%
1Y Performance:
+344.63%
1-Day Range:
$5.0604
$5.55
1-Week Range:
$4.635
$5.55
52-Week Range:
$0.8906
$7.20
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-23 | Upgrade | Needham | Hold → Buy |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-03-21 | Downgrade | Needham | Buy → Hold |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-20-21 | Reiterated | Needham | Buy |
| May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-21 | Initiated | Truist | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-12-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Aug-27-20 | Initiated | H.C. Wainwright | Buy |
| Aug-18-20 | Initiated | Needham | Buy |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Initiated | BofA/Merrill | Neutral |
| Jul-15-19 | Initiated | Cowen | Outperform |
| Jul-15-19 | Initiated | Morgan Stanley | Overweight |
| Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
Investing in Personalis Inc (PSNL): What You Must Know - Knox Daily
Metric Deep Dive: Understanding Personalis Inc (PSNL) Through its Ratios - The Dwinnex
Personalis Inc (PSNL) stock analysis: A simple moving average approach - US Post News
The growth track for Personalis Inc (PSNL) has changed recently - SETE News
Personalis Inc: Weathering Stock Market Storms with 269.46M Market Cap - The InvestChronicle
Personalis Inc (PSNL) stock analysis: A comprehensive overview - US Post News
Victory Capital Management Inc. Sells 4,170 Shares of PriceSmart, Inc. (NASDAQ:PSMT) - Defense World
Bank of New York Mellon Corp Buys 9,639 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
State of New Jersey Common Pension Fund D Has $1.85 Million Stake in PriceSmart, Inc. (NASDAQ:PSMT) - Defense World
Pantheon International (LON:PIN) Shares Cross Below Two Hundred Day Moving Average of $318.52 - MarketBeat
Pelatro share price: NSE SME stock lists at ₹75 per share premium. Details here | Stock Market News - Mint
ProSiebenSat.1 Media (OTCMKTS:PBSFY) Shares Up 8.7% - Defense World
Recent Insider Activity Could Benefit Personalis Inc (PSNL) - Knox Daily
Market Momentum: Personalis Inc (PSNL) Registers a -3.20 Decrease, Closing at 5.74 - The Dwinnex
Sei Investments Co. Has $57.04 Million Stock Position in Papa Johns International, Inc. (NASDAQ:PZZA) - Defense World
Psp Projects shares surge 3% after receiving orders worth Rs 554.92 crore - Business Upturn
Polaris Inc. (NYSE:PII) Shares Acquired by Benjamin F. Edwards & Company Inc. - Defense World
Massachusetts Financial Services Co. MA Sells 6,166 Shares of Polaris Inc. (NYSE:PII) - Defense World
MQS Management LLC Buys Shares of 3,973 Polaris Inc. (NYSE:PII) - Defense World
Federated Hermes Inc. Increases Stock Position in PriceSmart, Inc. (NASDAQ:PSMT) - Defense World
Personalis secures $7.5 million VA task order By Investing.com - Investing.com Australia
Polaris Inc. (NYSE:PII) Position Raised by Victory Capital Management Inc. - Defense World
Personalis secures $7.5 million VA task order - Investing.com India
Personalis secures $7.5 million VA task order - Investing.com
Analyzing the Impact of Earnings Reports on Personalis Inc Inc. (PSNL) Price Performance - The InvestChronicle
Kendall Capital Management Grows Position in PriceSmart, Inc. (NASDAQ:PSMT) - Defense World
Insider Buying: Tempus AI, Inc., Personalis Inc [PSNL] 10% Owner invested 3,500,000 shares - Knox Daily
Personalis, Inc. (NASDAQ:PSNL) has caught the attention of institutional investors who hold a sizeable 38% stake - Yahoo Finance
Piper Sandler Companies (NYSE:PIPR) Rating Reiterated by JMP Securities - Defense World
JMP Securities Reaffirms “Market Perform” Rating for Piper Sandler Companies (NYSE:PIPR) - Defense World
Polaris (NYSE:PII) Rating Increased to Hold at StockNews.com - Defense World
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir By Investing.com - Investing.com Australia
Palo Alto Networks Stock Could Rise On AI-Propelled Growth - Forbes
Comparing Prestige Consumer Healthcare (NYSE:PBH) and MediciNova (NASDAQ:MNOV) - Defense World
Piper Sandler Companies (NYSE:PIPR) Shares Purchased by Victory Capital Management Inc. - Defense World
Piper Sandler Companies (NYSE:PIPR) Receives "Market Perform" Rating from JMP Securities - MarketBeat
Prosus N.V. Continues Aggressive Share Buy-Back - TipRanks
Kuehn Law Encourages K, MNTX, SBT, and CPTN Investors to Contact Law Firm - ForexTV.com
Statera Biopharma (NASDAQ:STAB) & Pliant Therapeutics (NASDAQ:PLRX) Financial Analysis - Defense World
Personalis Inc (PSNL) expanding its growth trajectory ahead - SETE News
Plus Therapeutics director buys $6k worth of shares - Investing.com
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Purchased by Bank of New York Mellon Corp - Defense World
Piper Sandler Companies (NYSE:PIPR) Hits New 12-Month High at $269.34 - MarketBeat
Needham upgrades Personalis Inc (PSNL) stock to a Buy - Knox Daily
Examining Personalis Inc (PSNL) more closely is necessary - US Post News
ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test - Business Wire
Analytical Overview: Personalis Inc (PSNL)’s Ratios Tell a Financial Story - The Dwinnex
Acadian Asset Management LLC Boosts Stake in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Market contemplates Padini’s position as ‘value investment’ - The Edge Malaysia
(PSNL) Long Term Investment Analysis - Stock Traders Daily
Piper Sandler Companies (NYSE:PIPR) Sees Significant Growth in Short Interest - MarketBeat
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Personalis Inc Stock (PSNL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
| Tachibana Aaron | CFO AND COO |
Jul 30 '24 |
Sale |
2.97 |
742 |
2,204 |
175,270 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jun 17 '24 |
Sale |
1.29 |
5,055 |
6,521 |
127,751 |
| Tachibana Aaron | CFO AND COO |
Jun 17 '24 |
Sale |
1.29 |
7,176 |
9,257 |
176,012 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Jun 17 '24 |
Sale |
1.29 |
1,585 |
2,045 |
69,081 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 17 '24 |
Sale |
1.38 |
940 |
1,297 |
132,806 |
| Tachibana Aaron | CFO AND COO |
May 17 '24 |
Sale |
1.38 |
1,333 |
1,840 |
183,188 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
May 17 '24 |
Sale |
1.38 |
1,731 |
2,389 |
70,666 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Apr 30 '24 |
Sale |
1.37 |
4,523 |
6,197 |
72,397 |
| MYERS WOODROW A JR | Director |
Mar 01 '24 |
Buy |
1.67 |
10,000 |
16,700 |
26,116 |
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):